HIV Research & Clinical Practice, Volume 20, Issue 3 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

HIV Research & Clinical Practice, Volume 20, Issue 3 (2019)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Volume 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 2000
Download citations Download PDFs Download issue

Articles

Article
Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials
Yeon-Sook Kim, Shinichi Oka, Ploenchan Chetchotisakd, Amanda Clarke, Khuanchai Supparatpinyo, Anchalee Avihingsanon, Winai Ratanasuwan, Sasisopin Kiertiburanakul, Kiat Ruxrungtham, SangYoun Yang, Susan Guo, YaPei Liu, Moupali Das, Do Tran, Damian McColl, Roberto Corales, Chris Nguyen & David Piontkowsky
Pages: 73-81
Published online: 08 Jul 2019
AbstractforEfficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials | Full Text | References | PDF (941.8 KB)
  • 1908 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat
Emilie R Elliot, Elisa Bisdomini, Sujan Dilly Penchala, Saye Khoo, Nneka Nwokolo & Marta Boffito
Pages: 82-91
Published online: 23 Jul 2019
AbstractforPharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat | Full Text | References | PDF (753.2 KB)
  • 730 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Brief Reports

Brief Report
Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients
Francesca Lombardi, Simone Belmonti, Alberto Borghetti, Arturo Ciccullo, Gianmaria Baldin, Roberto Cauda, Massimiliano Fabbiani & Simona Di Giambenedetto
Pages: 92-98
Published online: 03 Sep 2019
AbstractforReduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients | Full Text | References | PDF (973 KB)
  • 456 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Brief Report
Lack of benefit with omega-3 fatty acid supplementation in HIV patients: A randomized pilot study
Antonio Navarro-Alcaraz, Juan Tiraboschi, Carmen Gómez, Beatriz Candas-Estébanez, María Saumoy, Arkaitz Imaz & Daniel Podzamczer
Pages: 99-105
Published online: 03 Sep 2019
AbstractforLack of benefit with omega-3 fatty acid supplementation in HIV patients: A randomized pilot study | Full Text | References | PDF (94.6 KB)
  • 386 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Parenting with HIV: a patient’s view on updated infant feeding guidelines in the US
Ciarra Covin
Comment | Published online: 4 Jun 2024
Open Access
Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIV
Arianna E. Kousari et al.
Article | Published online: 3 Jun 2024
Open Access
Understanding the lived experience research priorities for improving health-related quality of life in people living with HIV with cognitive impairment
Kate Alford et al.
Article | Published online: 3 Jun 2024
Open Access
Clinical characteristics and outcomes of people living with HIV and ocular syphilis during the COVID-19 health emergency
Edgar Pérez-Barragán et al.
Brief Report | Published online: 3 Jun 2024
Open Access